UnitedHealth Group Incorporated $UNH Shares Bought by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 44,230 shares of the healthcare conglomerate's stock after buying an additional 1,122 shares during the quarter. Maryland State Retirement & Pension System's holdings in UnitedHealth Group were worth $13,798,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Wealthcare Advisory Partners LLC grew its position in shares of UnitedHealth Group by 1.6% in the first quarter. Wealthcare Advisory Partners LLC now owns 5,215 shares of the healthcare conglomerate's stock valued at $2,731,000 after purchasing an additional 82 shares during the last quarter. GAMMA Investing LLC grew its position in shares of UnitedHealth Group by 7.4% in the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate's stock valued at $8,295,000 after purchasing an additional 1,089 shares during the last quarter. Finally, Sarasin & Partners LLP acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $290,321,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a research note on Tuesday. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. KeyCorp upped their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a research note on Wednesday. Zacks Research raised shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research note on Monday. Finally, Truist Financial increased their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $372.68.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $369.88 on Thursday. The company's fifty day simple moving average is $313.51 and its 200-day simple moving average is $352.54. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market cap of $334.99 billion, a PE ratio of 16.03, a P/E/G ratio of 2.35 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. The business's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.